ARTICLE | Company News
Mission Pharmacal, Retrophin Inc. sales and marketing update
June 9, 2014 7:00 AM UTC
Mission granted Retrophin exclusive rights to commercialize Thiola tiopronin in the U.S., where the product is approved to prevent the formation of cysteine stones in patients with cystinuria. Thiola...